ANI PHARMACEUTICALS INC — Director's Dealing 2013

Jun 21, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2013-06-19

Reporting Person: Jamnick Robert J. (VP, Quality & Product Develop.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-19	Common Stock	A	411964	—	Acquired	411964	Direct
2013-06-19	Common Stock	F	138254	—	Disposed	273710	Direct

Footnotes

F1: On June 19, 2013, the issuer's wholly-owned subsidiary merged with ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. (ANI). Holders of ANI's series D preferred stock received shares of the issuer's common stock as merger consideration. The reporting person received these shares of BioSante common stock in exchange for ANI series D preferred stock in the merger.

F2: Represents shares withheld for tax purposes.